Drugmaker Bristol-Myers Squibb Co. is expected to focus on a raft of recent positive research data and plans to seek approval for several drugs when it reports its second-quarter results before the stock market opens Thursday. WHAT TO WATCH FOR: Analysts anticipate detailed updates on several key ...

The following recalls have been announced: _ Good Health Inc., of Canutillo, Texas, is recalling select lots of the dietary supplement Vialipro because they could contain a compound that is chemically similar to the erectile dysfunction drug sildenafil. This compound could interact with nitrates found in some prescription drugs for diabetes, high blood pressure, high cholesterol ...

A majority of members of a key advisory committee have recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug increases the risk of heart problems, but only 12 of the 33-member expert panel voted to remove GlaxoSmithKline's one-time ...

PARIS (Reuters Life!) - A former Royal Air Force pilot with diabetes is preparing to break another record by touching down in all 50 U.S. states and show that the disease is no obstacle for enthusiasts who dream of flying. London-based Douglas Cairns starts his journey of 9,000 miles Sunday with a first leg from Hawaii, crossing the Pacific ...

LONDON (Reuters) - European regulators are launching a new probe into the safety of GlaxoSmithKline Plc's diabetes pill Avandia, adding to pressure on a medicine that already faces a grilling from U.S. experts next week. The European Medicines Agency (EMA) said on Friday its decision to review the risks and benefits of the drug followed the publication of fresh ...

CHICAGO (Reuters) - Aggressively controlling blood pressure in diabetics with heart disease may do little to reduce their risks of dying early and may even be dangerous, U.S. researchers said on Tuesday. They found that using a combination of drugs to keep diabetic patients' top blood pressure readings below 130 offered no benefit over those whose top reading was below ...

CHICAGO (Reuters) - Aggressive drug treatment to lower blood sugar, blood pressure and cholesterol in diabetics does little to prevent heart disease and strokes, but it does help prevent diabetic eye disease, nerve and kidney disease, U.S. researchers said on Tuesday. The five-year, U.S. government-backed study, presented at the American Diabetes Association meeting on Tuesday, was stopped temporarily in ...

Johnson & Johnson is grabbing for a share of the huge, fast-growing market for diabetes drugs, announcing a pair of partnerships Tuesday that could produce novel medicines for the disease. They would complement a very successful line of blood sugar testing and control equipment. The agreements, with companies in Sweden and California, to develop new drugs for Type 1 and Type ...

NEW YORK (Reuters Health) - An egg a day for breakfast probably won't increase your likelihood of developing type 2 diabetes, according to a new study. In the study, researchers failed to see a significant association between eating eggs occasionally or almost daily and the development of type 2 diabetes in nearly 4,000 older men and women. While eggs ...

NEW YORK (Reuters Life!) - People who eat brown rice or other whole grains seem to have a lower risk of developing diabetes than those who eat white rice, according to a U.S. study. A team of researchers from the Harvard School of Public Health and Brigham and Women's Hospital analyzed about 200,000 adults followed for up to ...